Annual Short Term Debt
$30.50 K
-$2.76 M-98.91%
December 31, 2023
Summary
- As of February 20, 2025, GDTC annual short term debt is $30.50 thousand, with the most recent change of -$2.76 million (-98.91%) on December 31, 2023.
- During the last 3 years, GDTC annual short term debt has fallen by -$1.76 million (-98.29%).
- GDTC annual short term debt is now -98.91% below its all-time high of $2.79 million, reached on December 31, 2022.
Performance
GDTC Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$27.60 K
-$2900.00-9.51%
June 30, 2024
Summary
- As of February 20, 2025, GDTC quarterly short term debt is $27.60 thousand, with the most recent change of -$2900.00 (-9.51%) on June 30, 2024.
- Over the past year, GDTC quarterly short term debt has stayed the same.
- GDTC quarterly short term debt is now -99.01% below its all-time high of $2.79 million, reached on December 31, 2022.
Performance
GDTC Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
GDTC Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -98.9% | 0.0% |
3 y3 years | -98.3% | 0.0% |
5 y5 years | -98.3% | 0.0% |
GDTC Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.9% | at low | -99.0% | at low |
5 y | 5-year | -98.9% | at low | -99.0% | at low |
alltime | all time | -98.9% | at low | -99.0% | at low |
CytoMed Therapeutics Limited Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $27.60 K(-9.5%) |
Dec 2023 | $30.50 K(-98.9%) | $30.50 K(+1.0%) |
Jun 2023 | - | $30.20 K(-98.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $2.79 M(+39.6%) | $2.79 M(+36.8%) |
Jun 2022 | - | $2.04 M(+2.0%) |
Dec 2021 | $2.00 M(+11.8%) | $2.00 M |
Dec 2020 | $1.79 M | - |
FAQ
- What is CytoMed Therapeutics Limited annual short term debt?
- What is the all time high annual short term debt for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual short term debt year-on-year change?
- What is CytoMed Therapeutics Limited quarterly short term debt?
- What is the all time high quarterly short term debt for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly short term debt year-on-year change?
What is CytoMed Therapeutics Limited annual short term debt?
The current annual short term debt of GDTC is $30.50 K
What is the all time high annual short term debt for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual short term debt is $2.79 M
What is CytoMed Therapeutics Limited annual short term debt year-on-year change?
Over the past year, GDTC annual short term debt has changed by -$2.76 M (-98.91%)
What is CytoMed Therapeutics Limited quarterly short term debt?
The current quarterly short term debt of GDTC is $27.60 K
What is the all time high quarterly short term debt for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly short term debt is $2.79 M
What is CytoMed Therapeutics Limited quarterly short term debt year-on-year change?
Over the past year, GDTC quarterly short term debt has changed by $0.00 (0.00%)